News on Tarceva from BioPortfolio.com http://www.BioPortfolio.com Consolidated Tarceva news from BioPortfolio.com Wed, 10 Feb 2010 06:20:56 GMT en Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037640&HITNO=0&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037640&THISHREF=http://c.moreover.com/click/here.pl%3fz2537199922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037640&HITNO=0&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037640&THISHREF=http://c.moreover.com/click/here.pl%3fz2537199922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037450&HITNO=1&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037450&THISHREF=http://c.moreover.com/click/here.pl%3fz2537084828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037450&HITNO=1&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037450&THISHREF=http://c.moreover.com/click/here.pl%3fz2537084828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPortland Business Journal: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037426&HITNO=2&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037426&THISHREF=http://c.moreover.com/click/here.pl%3fz2537073205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037426&HITNO=2&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037426&THISHREF=http://c.moreover.com/click/here.pl%3fz2537073205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCincinnati Business Journal: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037400&HITNO=3&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537056856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037400&HITNO=3&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537056856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037349&HITNO=4&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037349&THISHREF=http://c.moreover.com/click/here.pl%3fz2537040111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037349&HITNO=4&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037349&THISHREF=http://c.moreover.com/click/here.pl%3fz2537040111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037342&HITNO=5&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037342&THISHREF=http://c.moreover.com/click/here.pl%3fz2537037490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037342&HITNO=5&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037342&THISHREF=http://c.moreover.com/click/here.pl%3fz2537037490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhoenix Business Journal: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037339&HITNO=6&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037339&THISHREF=http://c.moreover.com/click/here.pl%3fz2537035256%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037339&HITNO=6&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037339&THISHREF=http://c.moreover.com/click/here.pl%3fz2537035256%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037233&HITNO=7&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037233&THISHREF=http://c.moreover.com/click/here.pl%3fz2536981517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037233&HITNO=7&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037233&THISHREF=http://c.moreover.com/click/here.pl%3fz2536981517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037184&HITNO=8&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037184&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037184&HITNO=8&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037184&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Strong operating performance for Roche in 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023958&HITNO=9&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023958&THISHREF=http://c.moreover.com/click/here.pl%3fz2528518445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023958&HITNO=9&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023958&THISHREF=http://c.moreover.com/click/here.pl%3fz2528518445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Pharma News: Strong operating performance for Roche in 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006240&HITNO=10&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006240&THISHREF=http://c.moreover.com/click/here.pl%3fz2520641933%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006240&HITNO=10&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006240&THISHREF=http://c.moreover.com/click/here.pl%3fz2520641933%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Diaceutics Identifies Critical Market Drivers for Personalized Medicine Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971898&HITNO=11&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971898&THISHREF=http://c.moreover.com/click/here.pl%3fz2502112479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971898&HITNO=11&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971898&THISHREF=http://c.moreover.com/click/here.pl%3fz2502112479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Tarceva Reprieve? FDA Delay Could Mean Little Either Wayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956004&HITNO=12&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956004&THISHREF=http://c.moreover.com/click/here.pl%3fz2494364911%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956004&HITNO=12&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956004&THISHREF=http://c.moreover.com/click/here.pl%3fz2494364911%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld Financial Watch: Tarceva Reprieve? FDA Delay Could Mean Little Either Wayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955760&HITNO=13&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955760&THISHREF=http://c.moreover.com/click/here.pl%3fz2494244298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955760&HITNO=13&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955760&THISHREF=http://c.moreover.com/click/here.pl%3fz2494244298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: ASCO GI: Agent Targets IGF Receptor in Pancreatic Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954909&HITNO=14&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954909&THISHREF=http://c.moreover.com/click/here.pl%3fz2493362562%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954909&HITNO=14&MSIZE=187&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tarceva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954909&THISHREF=http://c.moreover.com/click/here.pl%3fz2493362562%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedPage Today: